Which statement is true regarding sleep-wake disorders?

Choice A reason: Sleep-wake disorders rarely occur in isolation and are frequently bidirectional with other medical and psychiatric conditions. Comorbidities such as major depressive disorder, anxiety, and chronic pain syndromes are highly prevalent, complicating the clinical picture. Addressing these concurrent issues is a fundamental principle of psychiatric nursing and sleep medicine, as untreated sleep disturbances can exacerbate underlying mental health pathologies. Choice B reason: While many sleep disorders involve distress or circadian issues, this is not a universal clinical feature across the entire DSM-5-TR spectrum. For example, some disorders focus on hypersomnolence or specific parasomnias that do not necessarily involve a primary disruption of the circadian pacemaker. Consequently, stating they share these features as a defining rule is less accurate than acknowledging their comorbid nature. Choice C reason: The pathophysiology of sleep-wake disorders is highly heterogeneous, meaning they do not share a single sleep stage dysfunction. Disorders like narcolepsy involve rapid eye movement intrusions, whereas non-REM arousal parasomnias occur during slow-wave sleep. Because the architectural disturbances vary significantly between insomnia, apnea, and restless legs syndrome, asserting a common stage dysfunction is scientifically incorrect and clinically misleading. Choice D reason: Pharmacologic interventions are not the first-line treatment for all sleep-wake disorders; for instance, cognitive behavioral therapy for insomnia is the gold standard for chronic insomnia. Furthermore, conditions like obstructive sleep apnea require mechanical interventions like continuous positive airway pressure. Relying solely on pharmacology ignores evidence-based behavioral and structural treatments that often provide superior long-term outcomes and safety profiles.